LBF20306EO02: Difference between revisions

No edit summary
No edit summary
 
(14 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Hierarchy|{{PAGENAME}}}}
{{Hierarchy|{{PAGENAME}}}}
{{Lipid/Header}}


{{Metabolite
{{Metabolite
|LipidBank=DFA8111
|LipidBank=DFA8111
|LipidMaps=-
|LipidMaps=-
|SysName= (+-) 8 (9) -epoxy-5Z,11Z,14Z-eicosatrienoic acid
|SysName=dl-8 (9) -Epoxy- (cis-5,cis-11,cis-14) -eicosatrienoic acid
|Common Name=&&(+-) 8 (9) -epoxy-5Z,11Z,14Z-eicosatrienoic acid&&
|Common Name=&&(+-) -8 (9) -Epoxy- (5Z,11Z,14Z) -eicosatrienoic acid&&
|Source=(±)8(9)-EpETrE is biosynthesized in rat and rabbit liver microsomes by cytochrome P450 [[Reference:Oliw_EH:Guengerich_FP:Oates_JA:,J. Biol. Chem.,1982,257,3771|{{RelationTable/GetFirstAuthor|Reference:Oliw_EH:Guengerich_FP:Oates_JA:,J. Biol. Chem.,1982,257,3771}}]][[Reference:Chacos_N:Falck_JR:Wixtrom_C:Capdevila_J:,Biochem. Biophys. Res. Commun.,1982,104,916|{{RelationTable/GetFirstAuthor|Reference:Chacos_N:Falck_JR:Wixtrom_C:Capdevila_J:,Biochem. Biophys. Res. Commun.,1982,104,916}}]]. (±)8(9)-EpETrE is a major P450 metabolite in the renal cortex [[Reference:Zhang_JY:Prakash_C:Yamashita_K:Blair_IA:,Biochem. Biophys. Res. Commun.,1992,183,138|{{RelationTable/GetFirstAuthor|Reference:Zhang_JY:Prakash_C:Yamashita_K:Blair_IA:,Biochem. Biophys. Res. Commun.,1992,183,138}}]].
|Chemical Synthesis=
|Metabolism=
|Symbol=(+-)8(9)-EpETrE
|Biological Activity=(±)8(9)-EpETrE reduces the glomerular filtration rate (GFR) through cyclooxygenase-dependent preglomerular vasoconstriction [[Reference:Katoh_T:Takahashi_K:Capdevila_J:Karara_A:Falck:JR:Jacobson:HR:Badr:KF:,Am. J. Physiol.,1991,261,F578|{{RelationTable/GetFirstAuthor|Reference:Katoh_T:Takahashi_K:Capdevila_J:Karara_A:Falck:JR:Jacobson:HR:Badr:KF:,Am. J. Physiol.,1991,261,F578}}]]>.(±)8(9)-EpETrE has been shown to play a role in the recovery of depleted Ca^{2+} pools in cultured smooth muscle cells [[Reference:Graber_MN:Alfonso_A:Gill_DL:,J. Biol. Chem.,1997,272,29546|{{RelationTable/GetFirstAuthor|Reference:Graber_MN:Alfonso_A:Gill_DL:,J. Biol. Chem.,1997,272,29546}}]].
}}
}}


{{Lipid/Footer}}
{{Lipid/Footer}}

Latest revision as of 06:15, 21 October 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



(+-) -8 (9) -Epoxy- (5Z,11Z,14Z) -eicosatrienoic acid
LBF20306EO02.png
Structural Information
dl-8 (9) -Epoxy- (cis-5,cis-11,cis-14) -eicosatrienoic acid
  • (+-) -8 (9) -Epoxy- (5Z,11Z,14Z) -eicosatrienoic acid
(+-)8(9)-EpETrE
Formula C20H32O3
Exact Mass 320.23514489
Average Mass 320.46628
SMILES C(CC=CCC=CCC(O1)C1CC=CCCCC(O)=O)CCC
Physicochemical Information
(±)8(9)-EpETrE is biosynthesized in rat and rabbit liver microsomes by cytochrome P450 Oliw_EH et al. Chacos_N et al.. (±)8(9)-EpETrE is a major P450 metabolite in the renal cortex Zhang_JY et al..
(±)8(9)-EpETrE reduces the glomerular filtration rate (GFR) through cyclooxygenase-dependent preglomerular vasoconstriction Katoh_T et al.>.(±)8(9)-EpETrE has been shown to play a role in the recovery of depleted Ca^{2+} pools in cultured smooth muscle cells Graber_MN et al..
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20306EO02 See above. Chacos_N et al. 1982
n.a. LBF20306EO02 See above. Graber_MN et al. 1997
n.a. LBF20306EO02 See above. Katoh_T et al. 1991
n.a. LBF20306EO02 See above. Oliw_EH et al. 1982
n.a. LBF20306EO02 See above. Zhang_JY et al. 1992